1. 4CPS-099 Clinically relevant drug–drug interaction events in patients with abiraterone, enzalutamide or apalutamide treatment. (23rd March 2022) Authors: Bodega-Azuara, J; Vicente-Escrig, E; Cebolla-Beltrán, T; Bosó-Ribelles, V; Edo-Peñarrocha, J; Fortanet-García, M; Ferrando-Piqueres, R Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗